These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31897664)

  • 1. Exploring the Pharmacological Potentials of Biosurfactant Derived from Planococcus maritimus SAMP MCC 3013.
    Waghmode S; Swami S; Sarkar D; Suryavanshi M; Roachlani S; Choudhari P; Satpute S
    Curr Microbiol; 2020 Mar; 77(3):452-459. PubMed ID: 31897664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Insights of Halophilic
    Waghmode S; Suryavanshi M; Dama L; Kansara S; Ghattargi V; Das P; Banpurkar A; Satpute SK
    Front Microbiol; 2019; 10():235. PubMed ID: 30863371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavanones from the Twigs and Barks of Artocarpus lakoocha Having Antiplasmodial and Anti-TB Activities.
    Boonyaketgoson S; Du Y; Valenciano Murillo AL; Cassera MB; Kingston DGI; Trisuwan K
    Chem Pharm Bull (Tokyo); 2020; 68(7):671-674. PubMed ID: 32612002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding.
    Duca G; Pogrebnoi S; Boldescu V; Aksakal F; Uncu A; Valica V; Uncu L; Negres S; Nicolescu F; Macaev F
    Curr Top Med Chem; 2019; 19(8):609-619. PubMed ID: 30834838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD; Mahajan SS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents.
    Gholap S; Tambe M; Nawale L; Sarkar D; Sangshetti J; Damale M
    Arch Pharm (Weinheim); 2018 Feb; 351(2):. PubMed ID: 29292534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
    Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB
    Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
    Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies.
    Pisal MM; Nawale LU; Patil MD; Bhansali SG; Gajbhiye JM; Sarkar D; Chavan SP; Borate HB
    Eur J Med Chem; 2017 Feb; 127():459-469. PubMed ID: 28103537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antimalarial and antitubercular activities of meridianin derivatives.
    Yadav RR; Khan SI; Singh S; Khan IA; Vishwakarma RA; Bharate SB
    Eur J Med Chem; 2015 Jun; 98():160-9. PubMed ID: 26005918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
    Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent.
    Shaikh MH; Subhedar DD; Arkile M; Khedkar VM; Jadhav N; Sarkar D; Shingate BB
    Bioorg Med Chem Lett; 2016 Jan; 26(2):561-569. PubMed ID: 26642768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment Discovery for the Design of Nitrogen Heterocycles as Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors.
    Shelke RU; Degani MS; Raju A; Ray MK; Rajan MG
    Arch Pharm (Weinheim); 2016 Aug; 349(8):602-13. PubMed ID: 27320965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
    Joshi SD; Dixit SR; Kirankumar MN; Aminabhavi TM; Raju KV; Narayan R; Lherbet C; Yang KS
    Eur J Med Chem; 2016 Jan; 107():133-52. PubMed ID: 26580979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors: A combined in-silico and in-vitro analysis.
    Lone MY; Athar M; Gupta VK; Jha PC
    J Mol Graph Model; 2017 Sep; 76():172-180. PubMed ID: 28734205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non Nucleoside Reverse Transcriptase Inhibitors, Molecular Docking Studies and Antitubercular Activity of Thiazolidin-4-one Derivatives.
    Chitre TS; Patil SM; Sujalegaonkar AG; Asgaonkar KD; Khedkar VM; Garud DR; Jha PC; Gaikwad SY; Kulkarni SS; Choudhari A; Sarkar D
    Curr Comput Aided Drug Des; 2019; 15(5):433-444. PubMed ID: 30574853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.